Title | Type | SJR | H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2005) | %Female (2005) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
152 | Advances in Pharmacy | journal | 2 | 25 | 0 | 660 | 0 | 0 | 0.00 | 26.40 | 54.17 | ||
151 | Alcoholism: Clinical and Experimental Research | journal | 1.163 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
150 | Human Vaccines | journal | 63 | 39 | 0 | 651 | 0 | 0 | 0.00 | 16.69 | 39.65 | ||
149 | International Journal of Medicinal Mushrooms | journal | 41 | 37 | 0 | 1540 | 0 | 0 | 0.00 | 41.62 | 40.00 | ||
148 | Journal of Medical Toxicology | journal | 58 | 8 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 16.00 | ||
147 | Nanomedicine: Nanotechnology, Biology, and Medicine | journal | 151 | 48 | 0 | 1539 | 0 | 0 | 0.00 | 32.06 | 30.00 | ||
146 | Research in Social and Administrative Pharmacy | journal | 69 | 36 | 0 | 1507 | 0 | 0 | 0.00 | 41.86 | 43.21 | ||
145 | Journal of Immunotoxicology | journal | 0.215 Q3 | 48 | 32 | 11 | 1348 | 9 | 10 | 0.82 | 42.13 | 36.21 | |
144 | Metal-Based Drugs | journal | 0.155 Q4 | 40 | 0 | 12 | 0 | 6 | 12 | 0.00 | 0.00 | 0.00 | |
143 | National Toxicology Program technical report series | journal | 0.109 | 22 | 3 | 16 | 0 | 4 | 16 | 0.27 | 0.00 | 0.00 | |
142 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 5 | 16 | 506 | 0 | 16 | 0.00 | 101.20 | 25.00 | ||
141 | Pharmaceutical Biotechnology | journal | 0.637 Q1 | 28 | 0 | 16 | 0 | 34 | 16 | 0.00 | 0.00 | 0.00 | |
140 | Adverse Drug Reaction Bulletin | journal | 0.103 Q4 | 8 | 6 | 17 | 233 | 2 | 17 | 0.00 | 38.83 | 12.50 | |
139 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.111 Q4 | 29 | 23 | 19 | 1464 | 4 | 19 | 0.00 | 63.65 | 12.50 | |
138 | Journal of Infectious Disease Pharmacotherapy | journal | 0.201 Q3 | 6 | 0 | 24 | 0 | 5 | 24 | 0.21 | 0.00 | 0.00 | |
137 | Research Communications in Pharmacology and Toxicology | journal | 0.122 Q4 | 8 | 0 | 24 | 0 | 6 | 24 | 0.14 | 0.00 | 0.00 | |
136 | Strategies and Tactics in Organic Synthesis | book series | 0.466 Q3 | 10 | 17 | 32 | 1065 | 22 | 14 | 0.69 | 62.65 | 15.63 | |
135 | Advances in Pharmacology | journal | 0.205 Q3 | 86 | 20 | 34 | 1519 | 12 | 32 | 0.35 | 75.95 | 0.00 | |
134 | Neuropsychopharmacology Reports | journal | 22 | 1 | 36 | 0 | 9 | 34 | 0.00 | 0.00 | 0.00 | ||
133 | Pharmacopeial Forum (discontinued) | journal | 0.186 Q3 | 20 | 12 | 37 | 93 | 18 | 37 | 0.56 | 7.75 | 30.77 | |
132 | Journal of Cannabis Therapeutics | journal | 0.247 Q3 | 18 | 0 | 38 | 0 | 36 | 33 | 1.17 | 0.00 | 0.00 | |
131 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.464 Q1 | 82 | 11 | 40 | 2379 | 229 | 40 | 4.88 | 216.27 | 24.14 | |
130 | Current Protocols in Pharmacology | journal | 0.100 Q4 | 39 | 13 | 40 | 0 | 0 | 40 | 0.00 | 0.00 | 27.03 | |
129 | Journal of Pharmaceutical Finance, Economics and Policy | journal | 0.153 Q3 | 8 | 17 | 40 | 450 | 9 | 36 | 0.23 | 26.47 | 44.12 | |
128 | Journal of Natural Toxins | journal | 0.191 Q4 | 28 | 0 | 44 | 0 | 35 | 44 | 0.00 | 0.00 | 0.00 | |
127 | Topics in antiviral medicine | journal | 2.179 Q1 | 46 | 19 | 44 | 164 | 191 | 44 | 4.34 | 8.63 | 40.00 | |
126 | Dissolution Technologies | journal | 0.361 Q2 | 36 | 32 | 53 | 186 | 30 | 26 | 0.59 | 5.81 | 31.25 | |
125 | Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.] | journal | 0.108 Q4 | 31 | 22 | 57 | 0 | 8 | 57 | 0.17 | 0.00 | 28.21 | |
124 | Molecular Pharmaceutics | journal | 0.542 Q1 | 156 | 62 | 57 | 2124 | 128 | 53 | 2.25 | 34.26 | 27.75 | |
123 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.583 Q2 | 70 | 40 | 66 | 1045 | 119 | 62 | 1.71 | 26.13 | 21.67 | |
122 | Annual Review of Pharmacology and Toxicology | journal | 10.789 Q1 | 224 | 29 | 71 | 4036 | 1677 | 71 | 22.75 | 139.17 | 22.22 | |
121 | CNS Drug Reviews | journal | 0.791 Q2 | 64 | 27 | 71 | 1777 | 207 | 69 | 3.16 | 65.81 | 23.91 | |
120 | Pharmacological Reviews | journal | 9.872 Q1 | 254 | 30 | 73 | 5479 | 1707 | 71 | 16.30 | 182.63 | 19.05 | |
119 | Cardiovascular Drug Reviews | journal | 0.646 Q2 | 54 | 24 | 74 | 1540 | 176 | 74 | 2.20 | 64.17 | 21.74 | |
118 | Birth Defects Research Part B - Developmental and Reproductive Toxicology | journal | 0.384 Q3 | 58 | 32 | 76 | 1740 | 117 | 72 | 1.54 | 54.38 | 46.67 | |
117 | Medicinal Research Reviews | journal | 2.935 Q1 | 150 | 29 | 80 | 3798 | 789 | 80 | 9.22 | 130.97 | 33.07 | |
116 | Journal of Environmental Pathology, Toxicology and Oncology | journal | 0.689 Q2 | 50 | 29 | 83 | 1034 | 167 | 82 | 1.56 | 35.66 | 35.56 | |
115 | Drug Resistance Updates | journal | 2.708 Q1 | 132 | 29 | 87 | 3075 | 606 | 82 | 6.79 | 106.03 | 35.82 | |
114 | Journal of Herbal Pharmacotherapy | journal | 0.167 Q4 | 33 | 25 | 87 | 711 | 33 | 76 | 0.24 | 28.44 | 37.93 | |
113 | Cardiovascular Toxicology | journal | 0.829 Q2 | 64 | 33 | 89 | 1940 | 214 | 85 | 2.45 | 58.79 | 32.06 | |
112 | Drug and Chemical Toxicology | journal | 0.298 Q3 | 54 | 37 | 90 | 1296 | 104 | 90 | 1.00 | 35.03 | 40.57 | |
111 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.156 Q4 | 40 | 14 | 90 | 364 | 21 | 90 | 0.12 | 26.00 | 25.45 | |
110 | Clinical Research and Regulatory Affairs | journal | 0.138 Q3 | 18 | 10 | 91 | 376 | 18 | 84 | 0.18 | 37.60 | 31.82 | |
109 | Drug Metabolism Reviews | journal | 1.191 Q1 | 108 | 21 | 101 | 4103 | 459 | 99 | 4.10 | 195.38 | 31.15 | |
108 | IEEE Transactions on Nanobioscience | journal | 0.522 Q1 | 73 | 36 | 103 | 1821 | 200 | 100 | 1.98 | 50.58 | 22.83 | |
107 | Journal of Experimental Therapeutics and Oncology | journal | 0.643 Q2 | 40 | 17 | 104 | 685 | 209 | 103 | 1.83 | 40.29 | 32.10 | |
106 | Journal of Pharmacological and Toxicological Methods | journal | 0.428 Q3 | 83 | 71 | 104 | 2422 | 181 | 96 | 2.04 | 34.11 | 38.52 | |
105 | Biologicals | journal | 0.468 Q3 | 66 | 46 | 108 | 796 | 165 | 106 | 1.38 | 17.30 | 40.94 | |
104 | Journal of Texture Studies | journal | 0.400 Q2 | 66 | 33 | 109 | 893 | 71 | 108 | 0.55 | 27.06 | 36.47 | |
103 | Food and Drug Law Journal | journal | 0.199 Q3 | 23 | 33 | 112 | 31 | 24 | 109 | 0.21 | 0.94 | 31.25 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®